And Xu et al found that tumor necrosis factor-related apoptosis inducing ligand (TRAIL) could significantly increase the anti-tumor effects of doxorubicin through inducing the apoptosis of cancer cells [21]. Here, TNFSF10 is linked to neoplasm.